07 Feb. 2012
INDIANAPOLIS and WILMINGTON, N.C. - (February 7, 2012) - Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and BioDuro, a PPD® Company, announced today a three-year, multi-program discovery research agreement to generate novel molecules for synthesizing and testing fungicides, insecticides, and herbicides across a variety of crops.
The two companies will leverage BioDuro's deep expertise in medicinal chemistry and biochemistry and Dow AgroSciences' agrochemical capabilities in this new agrochemical discovery collaboration.
"We are very pleased to announce this novel collaboration between Dow AgroSciences and BioDuro, a respected leader in discovery services," said Daniel R. Kittle, Ph.D., global leader, research & development, for Dow AgroSciences. "This agreement is another example of our commitment to further enhance Dow AgroSciences' world-class discovery research capabilities by working with the best research teams around the globe to develop new solutions for our customers around the world."
Lee Babiss, Ph.D., executive vice president of global laboratory services for PPD, said, "This collaboration demonstrates BioDuro's commitment and flexibility in delivering discovery research services beyond the pharmaceutical industry. Combining our strong discovery expertise and first-class technologies with the premier scientists at Dow AgroSciences will accelerate discovery and development of novel molecules and advance research for the agrochemical industry."
Financial terms of the agreement were not disclosed.
About Dow AgroSciences
Dow AgroSciences, based in Indianapolis, Indiana, USA, develops leading-edge crop protection and plant biotechnology solutions to meet the challenges of the growing world. Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical Company and had annual global sales of $5.7 billion. Learn more at www.dowagro.com. Follow Dow AgroSciences on Facebook and YouTube or subscribe to our News Release RSS Feed.
BioDuro, acquired by PPD in 2009, is a leading drug discovery services company. It provides high-quality, integrated preclinical research and development services to biopharmaceutical clients, ranging from medicinal chemistry, discovery biology, pharmacology, DMPK and biologics. For more information, visit www.bioduro.com.